BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22778133)

  • 1. A WNT/p21 circuit directed by the C-clamp, a sequence-specific DNA binding domain in TCFs.
    Hoverter NP; Ting JH; Sundaresh S; Baldi P; Waterman ML
    Mol Cell Biol; 2012 Sep; 32(18):3648-62. PubMed ID: 22778133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unique DNA binding domain converts T-cell factors into strong Wnt effectors.
    Atcha FA; Syed A; Wu B; Hoverter NP; Yokoyama NN; Ting JH; Munguia JE; Mangalam HJ; Marsh JL; Waterman ML
    Mol Cell Biol; 2007 Dec; 27(23):8352-63. PubMed ID: 17893322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TCF C-clamp DNA binding domain expands the Wnt transcriptome via alternative target recognition.
    Hoverter NP; Zeller MD; McQuade MM; Garibaldi A; Busch A; Selwan EM; Hertel KJ; Baldi P; Waterman ML
    Nucleic Acids Res; 2014 Dec; 42(22):13615-32. PubMed ID: 25414359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic properties of Tcf1 and Tcf4 splice variants determine cell-type-specific Wnt/β-catenin target gene expression.
    Wallmen B; Schrempp M; Hecht A
    Nucleic Acids Res; 2012 Oct; 40(19):9455-69. PubMed ID: 22859735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoid enhancer factor/T cell factor expression in colorectal cancer.
    Waterman ML
    Cancer Metastasis Rev; 2004; 23(1-2):41-52. PubMed ID: 15000148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer.
    Hovanes K; Li TW; Munguia JE; Truong T; Milovanovic T; Lawrence Marsh J; Holcombe RF; Waterman ML
    Nat Genet; 2001 May; 28(1):53-7. PubMed ID: 11326276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function analysis of the C-clamp of TCF/Pangolin in Wnt/ß-catenin signaling.
    Ravindranath AJ; Cadigan KM
    PLoS One; 2014; 9(1):e86180. PubMed ID: 24465946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIC-5 is a novel repressor of lymphoid enhancer factor/T-cell factor-driven transcription.
    Ghogomu SM; van Venrooy S; Ritthaler M; Wedlich D; Gradl D
    J Biol Chem; 2006 Jan; 281(3):1755-64. PubMed ID: 16291758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subfunctionalization and neofunctionalization of vertebrate Lef/Tcf transcription factors.
    Klingel S; Morath I; Strietz J; Menzel K; Holstein TW; Gradl D
    Dev Biol; 2012 Aug; 368(1):44-53. PubMed ID: 22641013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sox17 modulates Wnt3A/beta-catenin-mediated transcriptional activation of the Lef-1 promoter.
    Liu X; Luo M; Xie W; Wells JM; Goodheart MJ; Engelhardt JF
    Am J Physiol Lung Cell Mol Physiol; 2010 Nov; 299(5):L694-710. PubMed ID: 20802155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Wnt kinase network alters nuclear localization of TCF-1 in colon cancer.
    Najdi R; Syed A; Arce L; Theisen H; Ting JH; Atcha F; Nguyen AV; Martinez M; Holcombe RF; Edwards RA; Marsh JL; Waterman ML
    Oncogene; 2009 Nov; 28(47):4133-46. PubMed ID: 19749792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
    J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt activation and alternative promoter repression of LEF1 in colon cancer.
    Li TW; Ting JH; Yokoyama NN; Bernstein A; van de Wetering M; Waterman ML
    Mol Cell Biol; 2006 Jul; 26(14):5284-99. PubMed ID: 16809766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
    Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
    Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentials.
    Mao CD; Byers SW
    Crit Rev Eukaryot Gene Expr; 2011; 21(3):207-36. PubMed ID: 22111711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymine DNA glycosylase promotes transactivation of β-catenin/TCFs by cooperating with CBP.
    Jia Y; Nie F; Du A; Chen Z; Qin Y; Huang T; Song X; Li L
    J Mol Cell Biol; 2014 Jun; 6(3):231-9. PubMed ID: 24748645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
    Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
    J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sp5 and Sp8 recruit β-catenin and Tcf1-Lef1 to select enhancers to activate Wnt target gene transcription.
    Kennedy MW; Chalamalasetty RB; Thomas S; Garriock RJ; Jailwala P; Yamaguchi TP
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3545-50. PubMed ID: 26969725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of wingless targets requires bipartite recognition of DNA by TCF.
    Chang MV; Chang JL; Gangopadhyay A; Shearer A; Cadigan KM
    Curr Biol; 2008 Dec; 18(23):1877-81. PubMed ID: 19062282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Yin-Yang of TCF/beta-catenin signaling.
    Barker N; Morin PJ; Clevers H
    Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.